Deferasirox API Manufacturers – GMP-Compliant Pharmaceutical Grade API
Sourcing Deferasirox often comes with challenges in purity, stability, and compliance. At Skanttr Lifescience LLP – Deferasirox API Manufacturers, we resolve these through WHO-GMP-certified production, stringent quality control, and complete documentation support.
Our Deferasirox API consistently meets global pharmacopoeial standards, ensuring dependable quality and expandability for formulation and generic manufacturers.
Deferasirox API Specifications
Each batch undergoes validated testing aligned with ICH and global pharmacopoeial standards. The table below outlines our standard quality profile.
| Test | Specification |
|---|---|
| Description | Complies with standard appearance |
| Identification | IR / HPLC method as per in-house SOP |
| Assay | ≥ 99.0% (on dried basis) |
| Related Substances | ≤ 0.5% total impurities |
| Loss on Drying | ≤ 0.5% |
| Residual Solvents | Within ICH limits |
| Heavy Metals | ≤ 10 ppm |
Note: Specifications may be customized per client or market-specific regulations.
Explore Our API Portfolio
Deferasirox is part of our expanding API portfolio across major therapeutic areas allowing formulation partners to source multiple actives from one reliable manufacturer:
Antidiabetics
Metformin, Dapagliflozin, Empagliflozin
Cardiovascular
Atorvastatin, Telmisartan
Gastro/PPI
Pantoprazole, Omeprazole intermediates
Antibiotics
Cefixime, Ciprofloxacin, Azithromycin
Specialty Molecules
Iron chelators, oncology APIs, and high-potency intermediates
How We Manufacture Deferasirox at Skanttr
We produce Deferasirox API through a well-defined process that prioritizes consistency, purity, and regulatory compliance. Each step is executed under controlled conditions to ensure the highest product integrity.
Reaction & Core Synthesis
The core structure is formed through a controlled reaction of a salicylic acid derivative with 4 hydrazinobenzoic acid, optimized for high yield and minimal impurities.
Purification
The crude product is purified using solvent systems such as methanol or ethyl acetate, followed by activated carbon or silica treatment to eliminate color and residual impurities.
Crystallization
Gradual cooling induces crystallization, forming stable, high-purity Deferasirox crystals with consistent solid-state properties.
Isolation & Drying
Final crystals are filtered, washed, and dried under controlled conditions to achieve defined moisture content and stability before analytical testing.
Meeting Global Quality & Compliance Benchmarks
Every batch is backed by complete regulatory documentation and produced in line with WHO-GMP, ISO, and ICH Q7 guidelines.
WHO-GMP, ISO, and ICH Q7 quality guidelines
Full traceability and documentation from raw material to finished batch
Availability of DMF, COA, and stability data for regulatory submissions
Analytical validation as per pharmacopoeial or client-defined methods
Packaging, Supply & Shelf-Life Assurance
We recognize that consistent quality depends as much on packaging and logistics as on synthesis. Every batch of Deferasirox API is securely packed and handled under validated conditions to maintain integrity during transit and storage.
MOQ
As per the project requirement (available for R&D and commercial volumes)
Packaging
Double-lined HDPE / fiber drums, sealed under inert conditions
Shelf Life
36 months under controlled storage
Storage
Store below 25°C, protected from moisture and direct sunlight
Lead Time
2–4 weeks for dispatch, depending on order volume and documentation scope
Your Reliable Deferasirox API Manufacturer – Skanttr Lifescience
We combine technical expertise, regulatory readiness, and strong supply reliability:
Consistent Purity & Yield
Each batch follows a validated multi-step synthesis, ensuring reproducible yield and tightly controlled impurity profiles that meet global pharmacopeial standards.
Flexible Supply Options
Available in R&D, pilot, and commercial-scale quantities with uniform quality across all volumes.
Global Export Experience
Supplied to regulated and semi-regulated markets with complete documentation, stability data, and logistics support.
Custom Synthesis Capability
Processes can be customized for impurity limits, particle size, or salt forms as per formulation or regulatory needs.
Responsive Technical Support
Our technical and regulatory teams coordinate through every stage—technology transfer, documentation, and batch qualification.
Ensure Continuous Deferasirox Supply for Your Formulations
Partner with us for high-purity Deferasirox API backed by global quality and compliance standards.
FAQ
It depends on the manufacturer, but many suppliers offer MOQs starting from gram-scale (for R&D) and scale up to kilograms or tons for commercial orders.
You should expect a Certificate of Analysis (CoA), stability data, validation reports, and, if applicable, a DMF or master file for regulatory submissions.
It depends on the destination market and molecule classification. Some countries require import permits, controlled substance licenses, or compliance with local regulatory norms.